Reexamining Paroxetine and Cognitive-Behavioral Therapy in Postpartum Depression and Anxiety
J Clin Psychiatry 2005;66(11):1494-1495 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece has no abstract, we have provided for your benefit the first 3 sentences of the full text.
The recent (September 2004) study by Misri et al.1
evaluating the use of paroxetine and cognitive-behavioral
therapy (CBT) to treat postpartum depression and anxiety is
timely and informative; however, I have several concerns.
The results of the study are not generalizable to the majority
of women with postpartum depression and anxiety. At best, the
sample is representative only of the very small subset of women
with severe comorbid anxiety and depression who are diagnosed
by their primary care physician and referred for specialty